Light-enhanced and fear-potentiated startle: Temporal characteristics and effects of α-helical corticotropin-releasing hormone

Biological Psychiatry

Volumn 54, Issue 10, 2003, Pages 1041-1048

  De Jongh, Reinoud ^a   Groenink, Lucianne ^a   Van Der Gugten, Jan ^a   Olivier, Berend ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Corticotropin releasing hormone; Fear; Light enhanced startle; Rats; Time course

Indexed keywords

CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AUDITORY STIMULATION; CHRONOSEQUENCE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DRUG DOSE REGIMEN; FEMALE; FUNCTIONAL ASSESSMENT; LIGHT EXPOSURE; LONG TERM EXPOSURE; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; STARTLE REFLEX;

EID: 0242643695     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00468-2     Document Type: Article

References (36)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Press, Washington, DC.
2. Barlow D.H., Chorpita B.F., Turovsky J. Fear, panic, anxiety, and disorders of emotion. Nebr Symp Motiv. 43:1996;251-328.
3. Birnbaum S.G., Davis M. Modulation of the acoustic startle reflex by infusion of corticotropin-releasing hormone into the nucleus reticularis pontis caudalis. Brain Res. 782:1998;318-323.
4. Brown J.S., Kalish H.I., Farber I.E. Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. J Exp Psychol. 41:1951;317-327.
5. Davis M. Diazepam and flurazepam Effects on conditioned fear as measured with the potentiated startle paradigm . Psychopharmacology. 62:1979;1-7.
6. Davis M., Falls W.A., Campeau S., Kim M. Fear-potentiated startle A neural and pharmacological analysis . Behav Brain Res. 58:1993;175-198.
7. Davis M., Schlesinger L.S., Sorenson C.A. Temporal specificity of fear conditioning Effects of different conditioned stimulus-unconditioned stimulus intervals on the fear-potentiated startle effect . J Exp Psychol Anim Behav Process. 15:1989;295-310.
8. Davis M., Shi C.-J. The extended amygdala Are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann N Y Acad Sci. 877:1999;281-291.
9. Davis M., Walker D.L., Lee Y. Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Ann N Y Acad Sci. 821:1997;305-331.
10. Deak T., Nguyen K.T., Ehrlich A.L., Watkins L.R., Spencer R.L., Maier S.F., et al. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology. 140:1999;79-86.
11. de Jongh R., Groenink L., van der Gugten J., Olivier B. The light-enhanced startle paradigm as a putative animal model for anxiety Effects of chlordiazepoxide, flesinoxan and fluvoxamine . Psychopharmacology. 159:2002;176-180.
12. Diamant M., Croiset G., De Wied D. The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats. Peptides. 13:1992;1149-1158.
13. Fendt M., Endres T., Apfelbach R. Temporary inactivation of the bed nucleus of the stria terminalis but not of the amygdala blocks freezing induced by trimethylthiazoline, a component of fox feces. J Neurosci. 23:2003;23-28.
14. Fendt M., Koch M., Schnitzler H.U. NMDA receptors in the pontine brainstem are necessary for fear potentiation of the startle response. Eur J Pharmacol. 318:1996;1-6.
15. Fendt M., Koch M., Schnitzler H.U. Corticotropin-releasing factor in the caudal pontine reticular nucleus mediates the expression of fear-potentiated startle in the rat. Eur J Neurosci. 9:1997;299-305.
16. Grillon C., Pellowski M., Merikangas K.R., Davis M. Darkness facilitates the acoustic startle reflex in humans. Biol Psychiatry. 42:1997;453-460.
17. Heinrichs S.C., Pich E.M., Miczek K.A., Britton K.T., Koob G.F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581:1992;190-197.
18. Hijzen T.H., Houtzager S.W., Joordens R.J., Olivier B., Slangen J.L. Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology. 118:1995;150-154.
19. Joordens R.J., Hijzen T.H., Peeters B.W., Olivier B. Fear-potentiated startle response is remarkably similar in two laboratories. Psychopharmacology. 126:1996;104-109.
20. Josselyn S.A., Shi C., Carlezon W.A. Jr, Neve R.L., Nestler E.J., Davis M. Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J Neurosci. 21:2001;2404-2412.
21. Kalin N.H., Sherman J.E., Takahashi L.K. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res. 457:1988;130-135.
22. Kalin N.H., Takahashi L.K. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems. Brain Res. 509:1990;80-84.
23. Kaplan H.I., Sadock B.J., Grebb J.A. Kaplan and Sadock's Synopsis of Psychiatry Behavioral Sciences, Clinical Psychiatry . 7th ed:1994;Williams & Wilkins, Baltimore.
24. Koch M. The neurobiology of startle. Prog Neurobiol. 59:1999;107-128.
25. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848:1999;141-152.
26. Korte S.M., Korte-Bouws G.A., Bohus B., Koob G.F. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol Behav. 56:1994;115-120.
27. 1A receptor ligands. Eur J Pharmacol. 156:1988;375-383.
28. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed:1998;Academic Press, San Diego, CA.
29. Sherman J.E., Kalin N.H. ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity. Pharmacol Biochem Behav. 30:1988;801-807.
30. Swerdlow N.R., Britton K.T., Koob G.F. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology. 2:1989;285-292.
31. Swerdlow N.R., Geyer M.A., Vale W.W., Koob G.F. Corticotropin-releasing factor potentiates acoustic startle in rats Blockade by chlordiazepoxide . Psychopharmacology. 88:1986;147-152.
32. Swiergiel A.H., Takahashi L.K., Kalin N.H. Attenuation of stress-induced behavior by antagonism of corticotropinreleasing factor receptors in the central amygdala in the rat. Brain Res. 623:1993;229-234.
33. Treit D., Aujla H., Menard J. Does the bed nucleus of the stria terminalis mediate fear behaviors. Behav Neurosci. 112:1998;379-386.
34. Walker D.L., Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry. 42:1997;461-471.
35. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci. 17:1997;9375-9383.
36. Walker D.L., Davis M. Light-enhanced startle Further pharmacological and behavioral characterization . Psychopharmacology. 159:2002;304-310.